Cigna Group $CI Holdings Decreased by MGO One Seven LLC

MGO One Seven LLC trimmed its stake in shares of Cigna Group (NYSE:CI) by 47.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,020 shares of the health services provider’s stock after selling 2,692 shares during the quarter. MGO One Seven LLC’s holdings in Cigna Group were worth $821,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. lifted its position in Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after purchasing an additional 840,098 shares during the period. GQG Partners LLC acquired a new stake in shares of Cigna Group in the second quarter valued at $1,628,918,000. Bank of America Corp DE grew its holdings in Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after acquiring an additional 256,677 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Cigna Group by 10.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after acquiring an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc acquired a new stake in Cigna Group in the 2nd quarter valued at about $542,779,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

NYSE:CI traded down $7.82 during midday trading on Friday, reaching $293.66. The stock had a trading volume of 2,427,984 shares, compared to its average volume of 1,441,425. The stock has a market capitalization of $77.60 billion, a P/E ratio of 12.96, a PEG ratio of 1.00 and a beta of 0.25. Cigna Group has a 1-year low of $255.53 and a 1-year high of $318.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm’s fifty day simple moving average is $285.81 and its 200-day simple moving average is $282.17.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. The firm had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.83 EPS. On average, equities research analysts forecast that Cigna Group will post 30.52 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio is presently 25.82%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Wall Street Analysts Forecast Growth

Several research firms recently commented on CI. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Thursday, August 27th. Piper Sandler restated an “overweight” rating on shares of Cigna Group in a report on Friday, October 23rd. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Guggenheim decreased their price target on Cigna Group from $361.00 to $347.00 and set a “buy” rating for the company in a research report on Friday. Finally, Evercore initiated coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Fourteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $335.70.

Cigna Group Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.